🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I/II study which intends to characterize the safety, tolera...
Status
Recruiting
Location
National Cheng Kung University Hospital
Start Date
2024-10-21
Trial ID
NCT06730009
Treatments Being Tested
Phase I part, Primary objective: the maximum tolerated dose of S-1 in the S...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2012-03
Trial ID
NCT01415713
Treatments Being Tested
A randomized phase II study to compare the efficacy and safety of SLOG or m...
Status
Completed
Location
National Institute of Cancer Research
Start Date
2018-03-26
Trial ID
NCT03443492
Treatments Being Tested
This is a prospective, open-label, exploratory, phase II basket clinical tr...
Status
Not Yet Recruiting
Location
Tongji Hospital
Start Date
2025-08-15
Trial ID
NCT07053150
Treatments Being Tested
To evaluate the following items in patients with locally advanced and metas...
Status
Completed
Location
Taiwan Cooperative Oncology Group, National Health Research Institutes
Start Date
2018-04-19
Trial ID
NCT03406299
Treatments Being Tested
Gemcitabine and nab-paclitaxel are one standard of care for metastatic panc...
Status
Active Not Recruiting
Location
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start Date
2021-12-28
Trial ID
NCT05026905
Treatments Being Tested
This study is a multi-center phase 3 trial to evaluate a treatment strategy...
Status
Unknown
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2018-07-01
Trial ID
NCT03398291
1. To evaluate the efficacy of neoadjuvant chemotherapy SLOG in localized p...
Status
Unknown
Location
Kaohsiung Medical University Hospital
Start Date
2021-09-03
Trial ID
NCT05048524
Treatments Being Tested